Gujarat Exclusive > Gujarat news > No extension of weekend curfew in Ahmedabad, night curfew to continue: Nitin Patel

No extension of weekend curfew in Ahmedabad, night curfew to continue: Nitin Patel

0
827

Gujarat’s deputy Chief Minister Nitin Patel on Sunday put to an end speculations about extension of the curfew in Ahmedabad and other cities in the state. Nitin Patel has said that the curfew imposed in Ahmedabad to contain the coronavirus pandemic will not be extended.

Patel, however, clarified that night curfew will continue in Ahmedabad, Surat, Vadodara and Rajkot till further notice.

Notably, a 57 hour curfew was imposed in Ahmedabad starting Friday night after the city recorded a considerable surge in COVID-19 cases. It resulted in panic buying in several parts of the city and speculations were doing the round that the government may extend the curfew to contain the COVID-19 cases.

Nitin Patel’s announcement has come as a major relief for many citizens.

Government not hiding COVID-19 data, says Nitin Patel

The deputy CM has refuted the allegations of the Opposition that government is manipulating the data related to COVID-19. He said the government is not hiding any data related to the coronavirus pandemic and that the right data and updates are all in the public domain.

Also Read: COVID-19 case tally nearing 91 lakh in India, deaths cross 1.33 lakh

Notably, the Congress has repeatedly attacked the government for hiding the real figures of COVID-19 pandemic in Gujarat. This apart, several media reports have also pointed out anomalies in government data related to COVID-19 cases and deaths.

Vaccine will be soon available

The deputy CM claimed that vaccines for the deadly virus will be soon available and the government is preparing a strategy on how the entire population of Gujarat will be vaccinated, especially those living in the rural areas.

Notably, several vaccine candidates are in the final stage of clinical trial. Many of these vaccine candidates have been found effective against the virus in phase 3 of the trial in the interim analysis reports.

India has high hopes from the vaccines under pipeline from AstraZeneca-Oxford and Moderna among others. While the AstraZeneca-Oxford vaccine will cost around Rs 1,000 for two mandatory doses, the Moderna vaccine will be expensive. It is likely to be priced Rs 1,900 upwards.

 

To read the latest news in Gujarati click here